Compare GSK plc (GSK) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Verizon Communications Inc — how do they compare? GSK plc trades at $52.66 (market cap $101.34B), while Verizon Communications Inc trades at $43.98 (market cap $178.84B). The key difference: Verizon Communications Inc is the larger of the two by market cap, and Verizon Communications Inc pays the higher dividend (6.61%). Which is the better fit depends on your goals.
| GSK | VZ | |
|---|---|---|
Market Cap | $101.34B | $178.84B |
Sector | Health | Media |
52-Week High | $61.18 | $51.38 |
52-Week Low | $36.20 | $38.40 |
Enterprise Value | $121.95B | $366.35B |
Dividend Yield | 3.49% | 6.61% |
Volume | — | 22,584,735 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Verizon (VZ) trades at $43.93, up 3.44% on the day, with a bearish technical signal but strong fundamentals including a P/E of 10.45 and a 6.66% dividend yield. Recent earnings beats and raised FY 2026 EPS guidance to $4.95–$4.99 reflect operational strength, though competition and technical weakness pose challenges. Cash flow trends show improving net cash generation, rising from $1.1B in 2024 to $14.9B in 2025.
The outlook is mixed: valuation appears attractive with a consensus price target of $48.06, but Starlink competition and bearish technicals present risks. Upside hinges on execution of growth initiatives and dividend sustainability, while downside could stem from industry disruption or earnings misses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
